ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for BEAM

Stock NameBeam Therapeutics Inc
TickerBEAM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS07373V1052

Show aggregate BEAM holdings

News associated with BEAM

Beam Therapeutics (NASDAQ:BEAM) Earns “Buy” Rating from HC Wainwright
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 249.19% from the company’s previous close. A number […] - 2025-09-17 02:46:44
Beam Therapeutics (NASDAQ:BEAM) Downgraded by Wall Street Zen to “Sell”
Wall Street Zen lowered shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a hold rating to a sell rating in a report published on Sunday. BEAM has been the topic of several other reports. Barclays lowered their price objective on shares of Beam Therapeutics from $25.00 to $21.00 and set an “equal weight” rating […] - 2025-09-15 04:42:44
Beam Therapeutics (NASDAQ:BEAM) Stock Rating Upgraded by Wall Street Zen
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other equities analysts have also commented on BEAM. Cantor Fitzgerald raised Beam Therapeutics to a “strong-buy” rating in a report on Monday, July […] - 2025-09-08 03:02:55
Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Recommendation of “Buy” from Brokerages
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned a consensus rating of “Buy” from the fourteen research firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and three have assigned a strong buy rating to the […] - 2025-08-07 02:38:51
Victory Capital Management Inc. Has $207,000 Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Victory Capital Management Inc. boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 18.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,612 shares of the company’s stock after purchasing an additional 1,618 shares during the period. Victory Capital […] - 2025-08-04 05:14:52
Bank of New York Mellon Corp Boosts Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Bank of New York Mellon Corp increased its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 14.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 318,026 shares of the company’s stock after buying an additional […] - 2025-07-24 04:27:08
Arizona State Retirement System Boosts Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Arizona State Retirement System raised its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 25.6% in the 1st quarter, Holdings Channel reports. The fund owned 25,534 shares of the company’s stock after purchasing an additional 5,197 shares during the period. Arizona State Retirement System’s holdings in Beam Therapeutics were worth $499,000 as of […] - 2025-07-22 07:42:58
Arizona State Retirement System Has $499,000 Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Arizona State Retirement System boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 25.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 25,534 shares of the company’s stock after purchasing an additional 5,197 shares during the period. Arizona State Retirement System’s holdings in Beam […] - 2025-07-22 06:57:02
D.A. Davidson & CO. Has $1.38 Million Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
D.A. Davidson & CO. boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 37.8% in the 1st quarter, HoldingsChannel reports. The firm owned 70,857 shares of the company’s stock after acquiring an additional 19,448 shares during the period. D.A. Davidson & CO.’s holdings in Beam Therapeutics were worth $1,384,000 as of its […] - 2025-07-09 05:53:15
QRG Capital Management Inc. Sells 870 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
QRG Capital Management Inc. cut its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 5.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,635 shares of the company’s stock after selling 870 shares during the period. QRG […] - 2025-06-24 04:46:59
Beam Therapeutics Inc. (NASDAQ:BEAM) Given Average Recommendation of “Buy” by Analysts
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned an average recommendation of “Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the […] - 2025-06-23 04:48:53
Implied ESGV Analyst Target Price: $116
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:27:28
Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Northern Trust Corp
Northern Trust Corp boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 7.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 740,506 shares of the company’s stock after acquiring an additional 49,415 shares during the period. Northern Trust […] - 2025-05-14 05:54:50
Stifel Financial Corp Acquires 2,976 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
Stifel Financial Corp boosted its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 27.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,662 shares of the company’s stock after acquiring an additional 2,976 shares during the quarter. Stifel Financial Corp’s […] - 2025-05-14 04:56:47
Beam Therapeutics (NASDAQ:BEAM) Trading Down 6.8% Following Weak Earnings
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares traded down 6.8% during mid-day trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $18.37 and last traded at $18.47. 326,775 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 1,947,803 shares. The stock […] - 2025-05-08 02:42:51
Dimensional Fund Advisors LP Has $38.16 Million Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Dimensional Fund Advisors LP boosted its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 24.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,538,398 shares of the company’s stock after purchasing an additional 298,067 shares during the period. Dimensional Fund Advisors […] - 2025-05-05 05:20:53
Implied VBK Analyst Target Price: $326
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-24 08:03:06
Beam Therapeutics Inc. (NASDAQ:BEAM) Stake Lifted by Sterling Capital Management LLC
Sterling Capital Management LLC raised its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 816.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,409 shares of the company’s stock after buying an additional 2,146 shares during the quarter. Sterling Capital Management LLC’s holdings in Beam […] - 2025-04-24 06:31:07
Beam Therapeutics Target of Unusually Large Options Trading (NASDAQ:BEAM)
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Investors acquired 10,060 put options on the company. This is an increase of approximately 1,089% compared to the typical daily volume of 846 put options. Beam Therapeutics Stock Up 3.9 % Beam Therapeutics stock opened at […] - 2025-04-24 02:30:49
Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by LPL Financial LLC
LPL Financial LLC grew its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 5.6% during the fourth quarter, Holdings Channel reports. The firm owned 27,698 shares of the company’s stock after acquiring an additional 1,462 shares during the quarter. LPL Financial LLC’s holdings in Beam Therapeutics were worth $687,000 as of […] - 2025-04-23 04:22:56
Federated Hermes Inc. Decreases Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Federated Hermes Inc. decreased its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 20.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 29,709 shares of the company’s stock after selling 7,792 shares during the quarter. Federated Hermes Inc.’s holdings in Beam Therapeutics were worth $737,000 as of its most recent SEC filing. […] - 2025-04-17 05:16:55
Beam Therapeutics Inc. (NASDAQ:BEAM) Holdings Decreased by Russell Investments Group Ltd.
Russell Investments Group Ltd. cut its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 6.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 176,181 shares of the company’s stock after selling 11,664 shares during the period. Russell Investments Group Ltd.’s holdings in Beam Therapeutics were worth $4,369,000 as of its […] - 2025-04-16 05:06:53
Geode Capital Management LLC Trims Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
Geode Capital Management LLC cut its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,804,374 shares of the company’s stock after selling 3,309 shares during the quarter. Geode Capital Management […] - 2025-04-15 05:01:01
JPMorgan Chase & Co. Sells 125,567 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
JPMorgan Chase & Co. lowered its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 19.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 513,671 shares of the company’s stock after selling 125,567 shares during the period. […] - 2025-04-14 04:36:51
Alliancebernstein L.P. Has $5.28 Million Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
Alliancebernstein L.P. lifted its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 149.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 212,804 shares of the company’s stock after purchasing an additional 127,494 shares during the quarter. Alliancebernstein L.P.’s holdings in […] - 2025-04-13 05:44:47
KLP Kapitalforvaltning AS Makes New Investment in Beam Therapeutics Inc. (NASDAQ:BEAM)
KLP Kapitalforvaltning AS purchased a new stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 13,400 shares of the company’s stock, valued at approximately $332,000. Other hedge funds and other institutional investors have […] - 2025-04-06 07:35:04
Mitsubishi UFJ Asset Management Co. Ltd. Has $244,000 Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)
Mitsubishi UFJ Asset Management Co. Ltd. lowered its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,613 shares of the company’s stock after selling 995 shares during the period. Mitsubishi UFJ Asset Management Co. […] - 2025-04-04 05:12:58
Stocks Tumble on Weaker US Consumer Spending and Sticky Price Pressures
The S&P 500 Index ($SPX ) (SPY ) today is down -1.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. June E-mini S&P futures (ESM25 ) are down -1.43%, and June E-mini Nasdaq futures... - 2025-03-28 18:31:32
AlphaQuest LLC Reduces Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
AlphaQuest LLC trimmed its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 92.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,610 shares of the company’s stock after selling 33,583 shares during the period. AlphaQuest LLC’s holdings in Beam Therapeutics […] - 2025-03-20 06:13:05
Beam Therapeutics (NASDAQ:BEAM) Earns Overweight Rating from Cantor Fitzgerald
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a research report issued on Wednesday,Benzinga reports. BEAM has been the subject of several other research reports. Guggenheim reaffirmed a “buy” rating and issued a $78.00 price objective on shares of Beam Therapeutics in a […] - 2025-03-14 04:44:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc BEAM holdings

DateNumber of BEAM Shares HeldBase Market Value of BEAM SharesLocal Market Value of BEAM SharesChange in BEAM Shares HeldChange in BEAM Base ValueCurrent Price per BEAM Share HeldPrevious Price per BEAM Share Held
2025-12-11 (Thursday)9,313USD 256,201BEAM holding increased by 1025USD 256,2010USD 1,025 USD 27.51 USD 27.4
2025-12-10 (Wednesday)9,313USD 255,176BEAM holding increased by 8568USD 255,1760USD 8,568 USD 27.4 USD 26.48
2025-12-09 (Tuesday)9,313USD 246,608BEAM holding decreased by -5774USD 246,6080USD -5,774 USD 26.48 USD 27.1
2025-12-08 (Monday)9,313USD 252,382BEAM holding increased by 93USD 252,3820USD 93 USD 27.1 USD 27.09
2025-12-05 (Friday)9,313USD 252,289BEAM holding decreased by -16950USD 252,2890USD -16,950 USD 27.09 USD 28.91
2025-12-04 (Thursday)9,313USD 269,239BEAM holding increased by 20209USD 269,2390USD 20,209 USD 28.91 USD 26.74
2025-12-03 (Wednesday)9,313BEAM holding decreased by -160USD 249,030BEAM holding increased by 27646USD 249,030-160USD 27,646 USD 26.74 USD 23.37
2025-12-02 (Tuesday)9,473BEAM holding increased by 64USD 221,384BEAM holding decreased by -4902USD 221,38464USD -4,902 USD 23.37 USD 24.05
2025-12-01 (Monday)9,409USD 226,286BEAM holding decreased by -12044USD 226,2860USD -12,044 USD 24.05 USD 25.33
2025-11-28 (Friday)9,409USD 238,330BEAM holding increased by 2823USD 238,3300USD 2,823 USD 25.33 USD 25.03
2025-11-27 (Thursday)9,409USD 235,507USD 235,5070USD 0 USD 25.03 USD 25.03
2025-11-26 (Wednesday)9,409USD 235,507BEAM holding increased by 3199USD 235,5070USD 3,199 USD 25.03 USD 24.69
2025-11-25 (Tuesday)9,409BEAM holding decreased by -96USD 232,308BEAM holding increased by 7800USD 232,308-96USD 7,800 USD 24.69 USD 23.62
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BEAM by Blackrock for IE00B3VWM098

Show aggregate share trades of BEAM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-16026.84523.300 23.654USD -3,785 22.48 Loss of -188 on sale
2025-12-02BUY6424.38023.335 23.439USD 1,500 22.47
2025-11-25SELL-9625.09023.330 23.506USD -2,257 22.42 Loss of -105 on sale
2025-11-24SELL-9623.87022.300 22.457USD -2,156 22.41 Loss of -4 on sale
2025-11-17SELL-35222.72020.800 20.992USD -7,389 22.43 Profit of 507 on sale
2025-11-12SELL-3222.66021.545 21.657USD -693 22.44 Profit of 25 on sale
2025-11-06SELL-3223.40022.170 22.293USD -713 22.44 Profit of 5 on sale
2025-11-05SELL-32023.57022.330 22.454USD -7,185 22.44 Loss of -4 on sale
2025-11-04SELL-6423.95022.580 22.717USD -1,454 22.44 Loss of -18 on sale
2025-11-03SELL-6425.19023.050 23.264USD -1,489 22.43 Loss of -53 on sale
2025-10-28BUY9626.43026.670 26.646USD 2,558 22.38
2025-10-24SELL-3227.96028.710 28.635USD -916 22.32 Loss of -202 on sale
2025-10-15BUY19227.19027.400 27.379USD 5,257 22.10
2025-10-02BUY3225.59025.890 25.860USD 828 22.06
2025-09-30BUY6424.27024.450 24.432USD 1,564 22.04
2025-09-11BUY12821.55021.590 21.586USD 2,763 22.01
2025-08-21SELL-3216.01016.100 16.091USD -515 22.05 Profit of 191 on sale
2025-07-31BUY9619.71020.144 20.101USD 1,930 22.10
2025-06-30SELL-6417.01017.730 17.658USD -1,130 22.34 Profit of 300 on sale
2025-06-25SELL-3216.76017.331 17.274USD -553 22.46 Profit of 166 on sale
2025-06-20SELL-6416.76017.303 17.249USD -1,104 22.58 Profit of 341 on sale
2025-05-23BUY3216.83017.110 17.082USD 547 23.49
2025-05-19SELL-3217.65518.000 17.966USD -575 23.69 Profit of 183 on sale
2025-05-15SELL-9617.25017.320 17.313USD -1,662 23.80 Profit of 623 on sale
2025-05-12SELL-3218.24019.150 19.059USD -610 23.96 Profit of 157 on sale
2025-05-09SELL-3217.41018.750 18.616USD -596 24.02 Profit of 173 on sale
2025-04-30SELL-3219.93020.080 20.065USD -642 24.39 Profit of 138 on sale
2025-04-24SELL-6420.17020.200 20.197USD -1,293 24.57 Profit of 280 on sale
2025-04-17SELL-3217.00017.200 17.180USD -550 24.91 Profit of 247 on sale
2025-04-15SELL-9617.28017.940 17.874USD -1,716 25.08 Profit of 692 on sale
2025-04-14SELL-9617.00017.210 17.189USD -1,650 25.17 Profit of 766 on sale
2025-04-09SELL-12816.37017.040 16.973USD -2,173 25.49 Profit of 1,090 on sale
2025-04-07SELL-22415.30016.040 15.966USD -3,576 25.74 Profit of 2,188 on sale
2025-04-04SELL-32015.27016.665 16.526USD -5,288 25.86 Profit of 2,986 on sale
2025-03-31BUY3219.53021.380 21.195USD 678 26.12
2025-03-19SELL-6423.64024.320 24.252USD -1,552 26.46 Profit of 141 on sale
2025-03-14SELL-19224.23025.805 25.648USD -4,924 26.57 Profit of 178 on sale
2025-03-13SELL-6425.06028.340 28.012USD -1,793 26.60 Loss of -91 on sale
2025-03-12SELL-1,08827.42028.490 28.383USD -30,881 26.58 Loss of -1,957 on sale
2025-03-07SELL-6428.48029.050 28.993USD -1,856 26.57 Loss of -155 on sale
2025-03-06SELL-9627.25027.500 27.475USD -2,638 26.56 Loss of -88 on sale
2025-03-03SELL-3225.10026.744 26.580USD -851 26.59 Profit of 0 on sale
2025-02-28SELL-19226.34027.290 27.195USD -5,221 26.60 Loss of -115 on sale
2025-02-26SELL-3227.89029.990 29.780USD -953 26.57 Loss of -103 on sale
2025-02-25SELL-9629.84032.710 32.423USD -3,113 26.51 Loss of -567 on sale
2025-02-18BUY16033.49035.250 35.074USD 5,612 25.81
2025-02-13BUY3228.61029.220 29.159USD 933 25.50
2025-02-12BUY3228.57028.800 28.777USD 921 25.43
2025-02-11BUY9626.85026.940 26.931USD 2,585 25.40
2025-02-06BUY28827.65028.950 28.820USD 8,300 25.28
2025-01-27BUY3225.91026.250 26.216USD 839 25.09
2024-12-30BUY16025.27026.410 26.296USD 4,207 25.03
2024-12-06BUY12826.71028.000 27.871USD 3,567 24.72
2024-12-05BUY3225.32025.970 25.905USD 829 24.70
2024-12-04BUY16026.02027.120 27.010USD 4,322 24.65
2024-11-29BUY16027.37028.100 28.027USD 4,484 24.35
2024-11-27BUY12827.20027.300 27.290USD 3,493 24.10
2024-11-26BUY3225.84027.190 27.055USD 866 24.02
2024-11-21BUY16023.58024.710 24.597USD 3,936 23.85
2024-11-20BUY9624.49025.870 25.732USD 2,470 23.81
2024-11-18BUY38424.12025.050 24.957USD 9,583 23.70
2024-11-12BUY25627.94030.655 30.384USD 7,778 23.42
2024-11-08BUY16027.06027.380 27.348USD 4,376 23.16
2024-11-07BUY48026.10027.165 27.059USD 12,988 22.93
2024-11-06BUY6426.62027.300 27.232USD 1,743 22.63
2024-10-31BUY3221.91022.610 22.540USD 721 22.30
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BEAM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19902,6942,1901,217,28174.2%
2025-09-181,122,5532,1891,640,60768.4%
2025-09-171,023,7333,8001,519,53867.4%
2025-09-16874,3396,1271,309,36766.8%
2025-09-15538,772247846,75063.6%
2025-09-12707,8961,4611,138,94962.2%
2025-09-11875,8556,8201,546,79656.6%
2025-09-10584,7521,614920,94163.5%
2025-09-09518,7102,293845,13961.4%
2025-09-08801,5075311,193,47367.2%
2025-09-051,238,7021,6372,031,03661.0%
2025-09-04900,7268001,465,11161.5%
2025-09-032,412,9004,9744,102,04458.8%
2025-09-02378,279147620,57161.0%
2025-08-29467,30111760,35261.5%
2025-08-28548,9910842,79965.1%
2025-08-27408,469600672,07960.8%
2025-08-26492,3140682,16272.2%
2025-08-25519,376200776,15266.9%
2025-08-22441,803100965,14445.8%
2025-08-21627,68501,043,50960.2%
2025-08-20809,0612641,230,70965.7%
2025-08-19782,9021,1001,398,03356.0%
2025-08-18556,5491,3941,234,38545.1%
2025-08-15461,18460779,89759.1%
2025-08-14848,848361,578,76053.8%
2025-08-13638,94001,311,07048.7%
2025-08-12670,9271,4551,113,55160.3%
2025-08-11466,6511,300802,25658.2%
2025-08-08323,809557746,12343.4%
2025-08-07372,64679763,80548.8%
2025-08-06669,329411,014,66366.0%
2025-08-051,074,6661,3471,597,18267.3%
2025-08-04529,057294703,68175.2%
2025-08-01702,8841,6191,140,50361.6%
2025-07-31484,476234942,89051.4%
2025-07-30702,8972,3681,181,92459.5%
2025-07-29557,7493,448868,26564.2%
2025-07-28508,5282,673759,68366.9%
2025-07-25416,9911,572695,00660.0%
2025-07-24538,292931,234,25143.6%
2025-07-23503,90010,0951,044,03548.3%
2025-07-22419,910309811,77851.7%
2025-07-21666,9243,4081,264,47252.7%
2025-07-18379,990371881,11543.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy